Free Access
Med Sci (Paris)
Volume 26, Number 2, Février 2010
Page(s) 153 - 158
Section M/S revues
Published online 15 February 2010
  1. Janoir C, Pechine S, Grosdidier C, et al. Cwp84, a surface-associated protein of Clostridium difficile, is a cysteine protease with degrading activity on extracellular matrix proteins. J Bacteriol 2007; 189 : 7174–80. [Google Scholar]
  2. Lyras D, O’Connor JR, Howarth PM, et al. Toxin B is essential for virulence of Clostridium difficile. Nature 2009; 458 : 1176–9. [Google Scholar]
  3. Jank T, Aktories K. Structure and mode of action of clostridial glucosylating toxins: the ABCD model. Trends Microbiol 2008; 16 : 222–9. [Google Scholar]
  4. Dupuy B, Govind R, Antunes A, et al. Clostridium difficile toxin synthesis is negatively regulated by TcdC. J Med Microbiol 2008; 57 : 685–9. [Google Scholar]
  5. Popoff MR, Rubin EJ, Gill DM, et al. Actin-specific ADP-ribosyltransferase produced by a Clostridium difficile strain. Infect Immun 1988; 56 : 2299–306. [Google Scholar]
  6. Carter GP, Lyras D, Allen DL, et al. Binary toxin production in Clostridium difficile is regulated by CdtR, a LytTR family response regulator. J Bacteriol 2007; 189 : 7290–301. [Google Scholar]
  7. Barbut F, Decre D, Lalande V, et al. Clinical features of Clostridium difficile-associated diarrhoea due to binary toxin (actin-specific ADP-ribosyltransferase)-producing strains. J Med Microbiol 2005; 54 : 181–5. [Google Scholar]
  8. Kyne L, Warny M, Qamar A, et al. Asymptomatic carriage of Clostridium difficile and serum levels of IgG antibody against toxin A. N Engl J Med 2000; 342 : 390–7. [Google Scholar]
  9. Kyne L, Warny M, Qamar A, et al. Association between antibody response to toxin A and protection against recurrent Clostridium difficile diarrhoea. Lancet 2001; 357 : 189–93. [Google Scholar]
  10. Barbut F, Beaugerie L, Petit JC. Clostridium difficile et pathologie digestive. EMC (Elsevier Masson Paris), Maladies infectieuses 2008; 8–038–H–20. [Google Scholar]
  11. McFarland LV, Mulligan ME, Kwok RY, et al. Nosocomial acquisition of Clostridium difficile infection. N Engl J Med 1989; 320 : 204–10. [Google Scholar]
  12. Kuijper EJ, Coignard B, Tull P. Emergence of Clostridium difficile-associated disease in North America and Europe. Clin Microbiol Infect 2006; 12 Suppl 6 : 2–18. [Google Scholar]
  13. Warny M, Pepin J, Fang A, et al. Toxin production by an emerging strain of Clostridium difficile associated with outbreaks of severe disease in North America and Europe. Lancet 2005; 366 : 1079–84. [Google Scholar]
  14. Wilcox MH, Mooney L, Bendall R, et al. A case-control study of community-associated Clostridium difficile infection. J Antimicrob Chemother 2008; 62 : 388–96. [Google Scholar]
  15. Beaugerie L, Flahault A, Barbut F, et al. Antibiotic-associated diarrhoea and Clostridium difficile in the community. Aliment Pharmacol Ther 2003; 17 : 905–12. [Google Scholar]
  16. Goorhuis A, Bakker D, Corver J, et al. Emergence of Clostridium difficile infection due to a new hypervirulent strain, polymerase chain reaction ribotype 078. Clin Infect Dis 2008; 47 : 1162–70. [Google Scholar]
  17. Bartlett JG, Gerding DN. Clinical recognition and diagnosis of Clostridium difficile infection. Clin Infect Dis 2008; 46 (suppl 1) : S12–8. [Google Scholar]
  18. Barbut F, Braun M, Burghoffer B, et al. Rapid diagnosis of toxigenic strains of Clostridium difficile in diarrheal stools by real-time PCR. J Clin Microbiol 2009; 47 : 1276–7. [Google Scholar]
  19. Gerding DN, Muto CA, Owens RC Jr. Treatment of Clostridium difficile infection. Clin Infect Dis 2008; 46 (suppl 1) : S32–42. [Google Scholar]
  20. Zar FA, Bakkanagari SR, Moorthi KM, et al. A comparison of vancomycin and metronidazole for the treatment of Clostridium difficile-associated diarrhea, stratified by disease severity. Clin Infect Dis 2007; 45 : 302–7. [Google Scholar]
  21. McFarland LV. Renewed interest in a difficult disease. Clostridium difficile infections: epidemiology and current treatment strategies. Curr Opin Gastroenterol 2009; 25 : 24–35. [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.